Jorge Erusalimsky

Biography

Born in Argentina, Jorge graduated in 1983 with a PhD in Biochemistry from the Hebrew University of Jerusalem. Following postdoctoral work with Nobel Laureate Cesar Milstein at the MRC Laboratory of Molecular Biology in Cambridge, UK, he held his first independent academic research position at King's College Medical School in London, where he pioneered work on megakaryocyte biology. In 1996 he joined University College London (UCL) as a Senior Lecturer in Medicine and was promoted to Reader in 2003. At UCL he initiated research on the cell and molecular biology of ageing. In 2006 Jorge was appointed to the Chair of Biomedical Sciences at Cardiff Metropolitan University. In Cardiff Jorge continues to develop research at the interphase between biology and medicine, with a focus on ageing and vascular diseases. Jorge is a fellow of the Royal Society of Biology and serves on the Editorial Boards of Gerontology and Mechanisms of Aging and Disease. He has held many research grants from charities, industry and the public sector, and is currently a partner of the European Commission-funded FRAILOMIC consortium which is dedicated to discovering biomarkers of frailty.

Research Interest

Jorge leads the Cellular Senescence and Pathophysiology Group. His research is recognised for demonstrating the occurrence of vascular cell senescence in artery walls and for discovering the origin of senescence-associated β-galactosidase, a commonly used biomarker of cellular senescence. Jorge was also one of the first in the UK to use blood stem-cells to produce megakaryocytes in a test tube. At Cardiff Met Jorge has also been involved in many research-related enabling and managerial activities, including; Acting as the Cardiff School of Health Sciences Associate Dean of Research and as Chair of the Cardiff School of Health Sciences Ethics Committee (2014-2015) Serving as a member of Cardiff Metropolitan University Intellectual Property Panel (2009-present) Designing and launching the new Cardiff School of Health Sciences Biomedical Research Laboratories (2007-2009)